rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
A genetic progression model of Braf(V600E)-induced intestinal tumorigenesis reveals targets for therapeutic intervention.
|
23845441 |
2013 |
rs727502902
|
|
TGTA |
0.700 |
CausalMutation |
CLINVAR |
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma.
|
19794125 |
2009 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
|
22180495 |
2012 |
rs121913361
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
|
22180495 |
2012 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
BRAF as a target for cancer therapy.
|
21426297 |
2011 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis.
|
20857202 |
2011 |
rs727502902
|
|
TGTA |
0.700 |
CausalMutation |
CLINVAR |
BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
|
21716161 |
2011 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
BRAFV600E mutation and its association with clinicopathological features of colorectal cancer: a systematic review and meta-analysis.
|
24594804 |
2014 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913355
|
|
T |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913355
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913355
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs121913361
|
|
G |
0.700 |
CausalMutation |
CLINVAR |
Clinical biomarkers in oncology: focus on colorectal cancer.
|
19537845 |
2009 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
Concomitant BRAF and PI3K/mTOR blockade is required for effective treatment of BRAF(V600E) colorectal cancer.
|
23549875 |
2013 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial.
|
22608338 |
2012 |
rs727502902
|
|
TGTA |
0.700 |
CausalMutation |
CLINVAR |
Distinguishing clinicopathologic features of patients with V600E and V600K BRAF-mutant metastatic melanoma.
|
22535154 |
2012 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.
|
20619739 |
2010 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib.
|
22448344 |
2012 |
rs727502902
|
|
TGTA |
0.700 |
CausalMutation |
CLINVAR |
Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma.
|
21190184 |
2011 |
rs113488022
|
|
T |
0.790 |
CausalMutation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913338
|
|
C |
0.700 |
CausalMutation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |
rs121913351
|
|
A |
0.700 |
CausalMutation |
CLINVAR |
Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity.
|
26619011 |
2016 |